Key result
COVID-19 pandemic linked to ~12% lower HF hospitalizations with no change in 1-year mortality.
Why the study?
The study was conducted to compare 1-year health care utilization and mortality in persons living with heart failure before and during the COVID-19 pandemic.
Does the COVID-19 pandemic period alter health care utilization and mortality in patients with heart failure compared to the pre-pandemic period?
Cohort (n=17,789)
Does the COVID-19 pandemic period alter health care utilization and mortality in patients with heart failure compared to the pre-pandemic period?
Answers are grounded in this paper and cite their sources.
The COVID-19 pandemic was associated with decreased hospitalizations and emergency department visits among heart failure patients, but resulted in no significant change in 1-year mortality.
Objective: To compare the 1-year health care utilization and mortality in persons living with heart failure (HF) before and during the coronavirus disease 2019 (COVID-19) pandemic. Patients and Methods: Residents of a 9-county area in southeastern Minnesota aged 18 years or older with a HF diagnosis on January 1, 2019; January 1, 2020; and January 1, 2021, were identified and followed up for 1-year for vital status, emergency department (ED) visits, and hospitalizations. Results: We identified 5631 patients with HF (mean age, 76 years; 53% men) on January 1, 2019, 5996 patients (mean age, 76 years; 52% men) on January 1, 2020, and 6162 patients (mean age, 75 years; 54% men) on January 1, 2021. After adjustment for comorbidities and risk factors, patients with HF in 2020 and patients with HF in 2021 experienced similar risks of mortality compared with those in 2019. After adjustment, patients with HF in 2020 and 2021 were less likely to experience all-cause hospitalizations (2020: rate ratio [RR], 0.88; 95% CI, 0.81-0.95; 2021: RR, 0.90; 95% CI, 0.83-0.97) compared with patients in 2019. Patients with HF in 2020 were also less likely to experience ED visits (RR, 0.85; 95% CI, 0.80-0.92). Conclusion: In this large population-based study in southeastern Minnesota, we observed an approximately 10% decrease in hospitalizations among patients with HF in 2020 and 2021 and a 15% decrease in ED visits in 2020 compared with those in 2019. Despite the change in health care utilization, we found no difference in the 1-year mortality between patients with HF in 2020 and those in 2021 compared with those in 2019. It is unknown whether any longer-term consequences will be observed.
No takes yet. Share an insight, caveat, or question.
Manemann et al. (2023) conducted a cohort in Heart failure (n=17,789). COVID-19 pandemic era (2020 and 2021) vs. Pre-COVID-19 era (2019) was evaluated on All-cause hospitalizations (2020 vs 2019) (RR 0.88, 95% CI 0.81-0.95).
Synapse has enriched 10 related papers. Consider them for comparative context: